$12.03
7.08% yesterday
Nasdaq, Nov 25, 09:48 pm CET
ISIN
US29772L1089
Symbol
ETON
Sector
Industry

Eton Pharmaceuticals, Inc. Stock price

$12.03
+3.92 48.34% 1M
+8.45 236.03% 6M
+7.65 174.66% YTD
+8.28 220.80% 1Y
+7.71 178.47% 3Y
+5.76 91.87% 5Y
+5.78 92.48% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.80 7.12%
ISIN
US29772L1089
Symbol
ETON
Sector
Industry

Key metrics

Market capitalization $310.81m
Enterprise Value $294.88m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 139.75
EV/Sales (TTM) EV/Sales 8.50
P/S ratio (TTM) P/S ratio 8.96
P/B ratio (TTM) P/B ratio 19.45
Revenue growth (TTM) Revenue growth 5.64%
Revenue (TTM) Revenue $34.68m
EBIT (operating result TTM) EBIT $-5.22m
Free Cash Flow (TTM) Free Cash Flow $2.11m
Cash position $20.26m
EPS (TTM) EPS $-0.21
P/E forward negative
P/S forward 8.15
EV/Sales forward 7.73
Short interest 0.83%
Show more

Is Eton Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Eton Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Eton Pharmaceuticals, Inc. forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Eton Pharmaceuticals, Inc. forecast:

Buy
100%

Financial data from Eton Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
35 35
6% 6%
100%
- Direct Costs 14 14
56% 56%
41%
21 21
14% 14%
59%
- Selling and Administrative Expenses 20 20
10% 10%
56%
- Research and Development Expense 5.17 5.17
61% 61%
15%
-4.13 -4.13
251% 251%
-12%
- Depreciation and Amortization 1.09 1.09
24% 24%
3%
EBIT (Operating Income) EBIT -5.22 -5.22
380% 380%
-15%
Net Profit -5.48 -5.48
346% 346%
-16%

In millions USD.

Don't miss a Thing! We will send you all news about Eton Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Eton Pharmaceuticals, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
DEER PARK, Ill., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired the U.S. rights to Amglidia (glyburide oral suspension, known as glibenclamide in Europe) for the treatment of neonatal diabetes mel...
Neutral
Seeking Alpha
13 days ago
Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants David Krempa – Chief Business Officer Sean Brynjelsen – Chief Executive Officer James Gruber – Chief Financial Officer Conference Call Participants Chase Knickerbocker – Craig-Hallum Operator Good afternoon, and welcome to the Eton Pharmaceuticals Third Quarter 2024 Finan...
Neutral
GlobeNewsWire
14 days ago
DEER PARK, Ill., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter ended September 30, 2024.
More Eton Pharmaceuticals, Inc. News

Company Profile

Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. It focuses on product candidates that are liquid in formulation, including injectables, oral liquids and ophthalmics. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Head office United States
CEO Sean Brynjelsen
Employees 30
Founded 2017
Website www.etonpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today